STOCK TITAN

Petiq Stock Price, News & Analysis

PETQ NASDAQ

Company Description

PetIQ, Inc. (formerly traded on Nasdaq under the symbol PETQ) is described as a pet medication, health and wellness company that focuses on giving pet parents convenient access to affordable products and veterinary services. According to the company’s public communications, PetIQ positions itself as a platform that helps pets "live their best lives" by combining pet medications, health and wellness items, and veterinarian services.

Business focus and operations

PetIQ states that its product business engages with pet parents through retail and e‑commerce sales channels. Its offerings include branded and distributed pet medications as well as health and wellness items. The company reports that its products reach consumers through traditional retail partners, e‑commerce outlets, and what it describes as more than 60,000 points of distribution in some of its communications.

The company also highlights a veterinarian services platform. PetIQ reports that this services business operates in over 2,600 mobile community clinic locations and wellness centers hosted at retail partners in 39 states. These locations are described as providing cost‑effective and convenient veterinary wellness services, with an emphasis on preventive care.

Manufacturing and facilities

PetIQ indicates that it manufactures and distributes pet products from facilities it characterizes as world‑class. In its more recent descriptions, the company notes a medications manufacturing facility in Omaha, Nebraska and a health and wellness manufacturing facility in Springville, Utah, along with additional manufacturing and distribution operations in Daytona Beach, Florida. Earlier descriptions also reference operations in Plano, Texas. The company has consistently identified Eagle, Idaho as its headquarters location.

Products and brands

PetIQ’s communications describe a portfolio that includes pet prescription medications, over‑the‑counter flea and tick preventatives, health and wellness supplements, and dog and cat treats. In prior descriptions, the company has cited brands such as Minties dental treats, Advecta and PetAction flea and tick preventatives, VetIQ health and wellness products, Delightibles cat treats, and Betsy Farms dog treats. In more recent news, PetIQ has highlighted NextStar, a flea and tick topical product that it describes as veterinarian‑recommended and available without a prescription through retailers and online channels.

In its marketing around NextStar, PetIQ emphasizes year‑round monthly prevention for fleas and ticks and notes that the product is sold through major retailers, online marketplaces, and through its network of preventive care community clinics and wellness centers.

Services footprint

PetIQ reports that its veterinarian services offering operates in thousands of mobile community clinic locations and wellness centers hosted at retail partners across dozens of states. These clinics are described as providing preventive and wellness‑oriented veterinary services at locations that are intended to be convenient for pet owners, such as large retail stores. This services footprint is presented as complementary to the company’s product business, with both aimed at convenient and affordable pet healthcare.

Ownership and listing status

PetIQ has disclosed that it was acquired by Bansk Group in an all‑cash transaction valued at approximately $1.5 billion. The company reported that this transaction closed on October 25, 2024. In connection with the completion of the acquisition, PetIQ stated that its shares would no longer trade on, and would be delisted from, the Nasdaq stock exchange, and that the company would become privately held while continuing to be operated independently by its executive team. Subsequent communications refer to PetIQ as a portfolio company of Bansk Group.

Strategic positioning

Across its public statements, PetIQ consistently describes itself as a pet medication, product and wellness company that aims to deliver a "smarter way" for pet parents to care for their animals. The company emphasizes themes of convenience, affordability, and access, citing its combination of retail and e‑commerce product distribution with a broad network of veterinary wellness clinics. PetIQ also highlights its belief that pets are an important part of the family and that they deserve high‑quality products and care.

Frequently asked questions about PetIQ (PETQ)

The following questions and answers summarize key points drawn directly from PetIQ’s public communications.

Stock Performance

$—
0.00%
0.00
Last updated:
62.37 %
Performance 1 year
$918.7M

SEC Filings

No SEC filings available for Petiq.

Financial Highlights

$328,941,000
Revenue (TTM)
$15,466,000
Net Income (TTM)
$57,878,000
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Petiq (PETQ)?

The current stock price of Petiq (PETQ) is $30.99 as of February 7, 2025.

What is the market cap of Petiq (PETQ)?

The market cap of Petiq (PETQ) is approximately 918.7M. Learn more about what market capitalization means .

What is the revenue (TTM) of Petiq (PETQ) stock?

The trailing twelve months (TTM) revenue of Petiq (PETQ) is $328,941,000.

What is the net income of Petiq (PETQ)?

The trailing twelve months (TTM) net income of Petiq (PETQ) is $15,466,000.

What is the earnings per share (EPS) of Petiq (PETQ)?

The diluted earnings per share (EPS) of Petiq (PETQ) is $0.49 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Petiq (PETQ)?

The operating cash flow of Petiq (PETQ) is $57,878,000. Learn about cash flow.

What is the profit margin of Petiq (PETQ)?

The net profit margin of Petiq (PETQ) is 4.70%. Learn about profit margins.

What is the operating margin of Petiq (PETQ)?

The operating profit margin of Petiq (PETQ) is 7.78%. Learn about operating margins.

What is the gross margin of Petiq (PETQ)?

The gross profit margin of Petiq (PETQ) is 26.84%. Learn about gross margins.

What is the current ratio of Petiq (PETQ)?

The current ratio of Petiq (PETQ) is 2.58, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Petiq (PETQ)?

The gross profit of Petiq (PETQ) is $88,283,000 on a trailing twelve months (TTM) basis.

What is the operating income of Petiq (PETQ)?

The operating income of Petiq (PETQ) is $25,581,000. Learn about operating income.

What does PetIQ do?

PetIQ describes itself as a pet medication, health and wellness company. According to its public statements, the company engages with pet parents through retail and e‑commerce channels to provide branded and distributed pet medications and health and wellness items, and it operates a veterinarian services platform focused on convenient, affordable preventive care.

How does PetIQ reach pet parents with its products?

PetIQ states that its product business engages with pet parents through retail and e‑commerce sales channels. In some communications, the company notes that its products are available in more than 60,000 points of distribution, including traditional retail partners and online marketplaces.

What types of services does PetIQ’s veterinarian platform offer?

The company describes its veterinarian services offering as operating in over 2,600 mobile community clinic locations and wellness centers hosted at retail partners in 39 states. These locations are characterized as providing cost‑effective and convenient veterinary wellness services, with an emphasis on preventive care.

Where is PetIQ headquartered and where does it manufacture products?

PetIQ identifies Eagle, Idaho as its headquarters. It reports manufacturing and distributing pet products from facilities in Omaha, Nebraska, Springville, Utah and Daytona Beach, Florida, and earlier descriptions also referenced operations in Plano, Texas.

What product categories does PetIQ highlight?

In its descriptions, PetIQ highlights pet prescription medications, over‑the‑counter flea and tick preventatives, health and wellness supplements, and dog and cat treats. The company has also emphasized specific flea and tick prevention products such as NextStar in its news releases.

Is PetIQ still publicly traded under the ticker PETQ?

No. PetIQ announced that its acquisition by Bansk Group was successfully completed on October 25, 2024. In connection with that transaction, the company stated that its shares would no longer trade on and would be delisted from the Nasdaq stock exchange, and that PetIQ would become a privately held company.

Who owns PetIQ now?

PetIQ has reported that it was acquired by Bansk Group in an all‑cash transaction valued at approximately $1.5 billion. Following completion of the transaction, PetIQ has been described as a portfolio company of Bansk Group.

What is NextStar and how is it related to PetIQ?

NextStar is described in PetIQ’s news releases as a PetIQ brand of flea and tick topical protection available without a prescription. The company states that NextStar is veterinarian‑recommended and is sold through retailers, online channels, and PetIQ’s network of preventive care community clinics and wellness centers.

How extensive is PetIQ’s clinic and wellness center network?

PetIQ reports that its veterinarian services platform operates in over 2,600 community clinic locations and wellness centers hosted at retailers in 39 states. These locations are presented as part of the company’s effort to provide convenient and affordable veterinary wellness services.

What happened to PetIQ’s Nasdaq listing after the Bansk Group acquisition?

In its announcement of the completed transaction, PetIQ stated that, upon completion of the acquisition by Bansk Group, its common stock would no longer be listed on the Nasdaq Stock Market and that the company would be privately held while continuing to be operated independently by its executive team.